Talk:Merck & Co.
From Wikipedia, the free encyclopedia
[edit] Section on research at Merck
Adding something here for inclusion in a Research section should one be made.
Research Management
Dr. Anthony Ford-Hutchinson, Executive Vice President, Worldwide Basic Research, Merck Research Laboratories.
- ↑ CHI World Pharmaceutical Congress 2005 Website and final agenda in print form. Verified 03-07-2005.
- Dr. Peter S Kim, President, Merck Research Laboratories- originally from the Whitehead Institute at M.I.T.
[edit] Rosetta Biosoftware merge
See Talk:Rosetta Biosoftware - I would support this merge. Just another star in the night T | @ | C 06:17, 3 April 2006 (UTC)
I support this merge too. The information is useful and will add more value when an individual is researching about Merck. Thanks, KP.
This merge makes sense, personnel at Rosetta are considered Merck employees for benefits, pay and retirement. As noted in the opposition, they do sell their software outside of Merck and Rosetta Biosoftware facilities are not directly accessible to all Merck employees. Rosetta is a great place to work and shares corporate culture and company events with Merck. It is interesting that no mention of Rosetta is found on Merck's websites, however, these two references were found showing their relationship. http://www.forbes.com/2001/05/11/0511rosetta.html http://www.wabio.com/industry/directory/companybyid?companyid=120 Examining Merck's mission statements and core competencies it's understandable that there is no mention.
[edit] Oppose the Merge
I oppose merging Rosetta Biosoftware with Merck because Rosetta Biosoftware is a business unit of Rosetta Inpharmatics, LLC, and Rosetta Inpharmatics LLC is a wholly owned subsidiary of Merck. Rosetta Biosoftware sells software commercially to many companies outside of Merck, including Merck competitors. If you look at any advertising or branding of Rosetta Biosoftware, you'll see no mention or indication of Merck. Because Rosetta Biosoftware also supports Merck Research Labs, instead of a merge, I propose that the Merck entry be edited to refer to Rosetta Biosoftware with a link to this entry as a separate one.
~gf
- I have no objection to a reference made listing wholly owned subsidiaries of Merck within the article, but Rosetta Biosoftware is an independent entity and its content should not be merged into Merck, a mention would be acceptable. Kershner 13:33, 28 August 2006 (UTC)
